Literature Citations
1. Pyrazole and Triazole Derivatives as Mycobacterium tuberculosis UDP-galactopyranose Inhibitors. Ahmed, D.M., J.F.M. Chen, and D.A.R. Sanders. Pharmaceuticals, 2022. 15(2): 197. PMID[35215309]. PMCID[PMC8874540].
[PubMed]. TB_03_2022.
2. Synthesis, Characterization and Antimycobacterial Activity of Some Substituted Phenylpyridazinone Derivatives. Alghamdi, S., M. Imran, M. Kamal, and M. Asif. Pharmaceutical Chemistry Journal, 2022. 55: 1367-1371. ISI[000765036200002].
[WOS]. TB_03_2022.
3. Antimycobacterial Assessment and Microwave-assisted Synthesis of 2-Aryl-3-(4-methylphenylamino)thiazolidin-4-one Derivatives. Alghamdi, S., M. Kamal, and M. Asif. Letters in Organic Chemistry, 2022. 19(3): p. 250-255. ISI[000754988700011].
[WOS]. TB_03_2022.
4. Synthesis and Characterization of Novel 2-Acyl-3-trifluoromethylquinoxaline 1,4-dioxides as Potential Antimicrobial Agents. Buravchenko, G.I., D.A. Maslov, M.S. Alam, N.E. Grammatikova, S.G. Frolova, A.A. Vatlin, X. Tian, I.V. Ivanov, O.B. Bekker, M.A. Kryakvin, O.A. Dontsova, V.N. Danilenko, T. Zhang, and A.E. Shchekotikhin. Pharmaceuticals, 2022. 15(2): 155. PMID[35215268]. PMCID[PMC8877263].
[PubMed]. TB_03_2022.
5. An Amiloride Derivative Is Active against the F1FO-ATP Synthase and Cytochrome bd Oxidase of Mycobacterium tuberculosis. Hards, K., C.Y. Cheung, N. Waller, C. Adolph, L. Keighley, Z.S. Tee, L.K. Harold, A. Menorca, R.S. Bujaroski, B.J. Buckley, J.D.A. Tyndall, M.B. McNeil, K.Y. Rhee, H.K. Opel-Reading, K. Krause, L. Preiss, J.D. Langer, T. Meier, E.J. Hasenoehrl, M. Berney, M.J. Kelso, and G.M. Cook. Communications Biology, 2022. 5(1): 166. PMID[35210534]. PMCID[PMC8873251].
[PubMed]. TB_03_2022.
6. Discovery of 3H-Pyrrolo[2,3-c]quinolines with Activity against Mycobacterium tuberculosis by Allosteric Inhibition of the Glutamate-5-kinase Enzyme. Panciera, M., E. Lence, Á. Rodríguez, B. Gracia, J.A. Aínsa, C. Marco-Marín, V. Rubio, C.R. Duarte Correia, and C. González-Bello. European Journal of Medicinal Chemistry, 2022. 232: 114206. PMID[35219949].
[PubMed]. TB_03_2022.
7. Synthesis and Biological Evaluation of Tetrahydroisoquinoline-derived Antibacterial Compounds. Payne, M., A.L. Bottomley, A. Och, H.G. Hiscocks, A.P. Asmara, E.J. Harry, and A.T. Ung. Bioorganic & Medicinal Chemistry, 2022. 57: 116648. PMID[35124457].
[PubMed]. TB_03_2022.
8. Design, Synthesis and Molecular Docking Studies of Imidazole and Benzimidazole Linked Ethionamide Derivatives as Inhibitors of InhA and Antituberculosis Agents. Raghu, M.S., C.B. Pradeep Kumar, K. Yogesh Kumar, M.K. Prashanth, M.Y. Alshahrani, I. Ahmad, and R. Jain. Bioorganic & Medicinal Chemistry Letters, 2022. 60: 128604. PMID[35123004].
[PubMed]. TB_03_2022.
9. Efficient Synthesis of Benzothiazinone Analogues with Activity against Intracellular Mycobacterium tuberculosis. Richter, A., G. Narula, I. Rudolph, R.W. Seidel, C. Wagner, Y. Av-Gay, and P. Imming. ChemMedChem, 2022. 17(6): e202100733. PMID[34939744].
[PubMed]. TB_03_2022.
10. Zn(II) Complexes with a New Isoniazid Ligand: Synthesis, Structural Characterization and Antimycobacterial Activity. Santiago, P.H.O., M.A.S. Bessa, R.P. Menezes, C.H.G. Martins, and C.C. Gatto. Journal of Coordination Chemistry, 2022. 2022: ISI[000770538400001].
[WOS]. TB_03_2022.
11. Mycobactin Analogues with Excellent Pharmacokinetic Profile Demonstrate Potent Antitubercular Specific Activity and Exceptional Efflux Pump Inhibition. Shyam, M., H. Verma, G. Bhattacharje, P. Mukherjee, S. Singh, S. Kamilya, P. Jalani, S. Das, A. Dasgupta, A. Mondal, A.K. Das, A. Singh, F. Brucoli, C. Bagneris, R. Dickman, V.N. Basavanakatti, P.N. Babu, V. Sankaran, A. Dev, B.N. Sinha, S. Bhakta, and V. Jayaprakash. Journal of Medicinal Chemistry, 2022. 65(1): p. 234-256. PMID[34981940].
[PubMed]. TB_03_2022.
Literature Citations
This month, no relevant Mycobacterium patents were identified.